author-photo

Carsten Müller-Tidow

University of Münster
Martin Luther University of Halle-Wittenberg

355

Papers

13300

Citations

Citation Trend

Filter By

Papers (255) Sort By

Journal Conference Others

Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide - an international collaborative study.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (2)
Cryostorage to What End? – Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients

2021 Transfusion Medicine and Hemotherapy
Show All
- Source
- Cite
- Save
Citations (0)
Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Hotspot DNMT3A mutations in Clonal Hematopoiesis and Acute Myeloid Leukemia sensitize cells to Azacytidine via viral mimicry response

2021
Show All
- Source
- Cite
- Save
Citations (4)
Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (3)
Combinatorial drug-microenvironment interaction mapping reveals cell-extrinsic drug resistance mechanisms and clinically relevant patient subgroups in CLL

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Genomic Investigation and Successful Containment of an Intermittent Common Source Outbreak of OXA-48-Producing Enterobacter cloacae Related to Hospital Shower Drains.

2021 Microbiology spectrum
Show All
- Source
- Cite
- Save
Citations (0)
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (7)
Rationale and Design of GnG-Trial: A Randomized Phase-III Study to Compare Two Schedules of Gemtuzumab Ozogamicin as Adjunct to Intensive Induction Therapy and to Compare Double-Blinded Intensive Postremission Therapy with or Without Glasdegib in Older Patients with Newly Diagnosed AML

2021
Show All
- Source
- Cite
- Save
Citations (0)